Literature DB >> 20132404

Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation.

Javier Modrego1, Luis Maroto, Juan Tamargo, Luis Azcona, Petra Mateos-Cáceres, Antonio Segura, Rosario Moreno-Herrero, Nicasio Pérez-Castellanos, Eva Delpón, Julián Pérez-Villacastín, Enrique Rodríguez, Carlos Macaya, Antonio J López-Farré.   

Abstract

INTRODUCTION: The objective was to compare by proteomics the expression of proteins associated with the cytoskeleton, energetic metabolism, and cardiac cytoprotection between left atrial appendages (LAA) and right atrial appendages (RAA) obtained from patients with mitral valve disease both in sinus rhythm (SR, n = 6) and in permanent atrial fibrillation (AF, n = 11). METHODS AND
RESULTS: Samples from RAA and LAA were obtained from the same patient. Proteins were separated in 2-dimensional electrophoresis and identified by mass spectrometry. LAA from SR patients upexpressed alpha-actin isotype 1 and desmin isotypes 3 and 5 with respect to RAA. In LAA from AF patients were upexpressed cardiac alpha-actin isotypes 1 and 2, tropomyosin alpha- and beta-chains, and myosin light chain embryonic muscle/atrial isoform with respect to LAA from SR patients. In RAA from AF patients also upexpressed different cytoskeleton associated proteins with respect to RAA from SR patients. Different energetic metabolism-associated proteins were upexpressed in LAA and RAA from AF with respect those from SR patients. In AF patients, the expression of proteins associated with cardiac cytoprotection such as gluthatione-S-transferase, heat shock protein (Hsp) 27, and different Hsp60 isotypes, were higher in RAA but not in LAA with respect to the corresponding appendages in SR patients.
CONCLUSIONS: For each individual patient RAA and LAA showed a similar level of proteins expressed associated with cytoskeleton, energetic metabolism, and cardiac cytoprotection. There were more differences in the level of proteins associated with the above-mentioned mechanisms between the atrial appendages from AF with respect to SR patients, which may open new targets for drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132404     DOI: 10.1111/j.1540-8167.2010.01718.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  13 in total

1.  Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers.

Authors:  Ana Custodio; Antonio J López-Farré; José J Zamorano-León; Petra J Mateos-Cáceres; Carlos Macaya; Trinidad Caldés; Miguel de la Hoya; Elena Olivera; Javier Puente; Eduardo Díaz-Rubio; Pedro Pérez-Segura
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-07       Impact factor: 4.553

2.  Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients.

Authors:  Antonio J López-Farré; Pablo Rodriguez-Sierra; Javier Modrego; Antonio Segura; Naiara Martín-Palacios; Ana M Saiz; José J Zamorano-León; Juan Duarte; Javier Serrano; Guillermo Moñux
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

3.  Proteomics: A promising approach to discover new biomarkers for atrial fibrillation.

Authors:  Jia Song; Dobromir Dobrev; Na Li
Journal:  Int J Cardiol       Date:  2021-10-26       Impact factor: 4.164

4.  Identification of altered plasma proteins by proteomic study in valvular heart diseases and the potential clinical significance.

Authors:  Ge Gao; Chao Xuan; Qin Yang; Xiao-Cheng Liu; Zhi-Gang Liu; Guo-Wei He
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Upregulation of sestrins protect atriums against oxidative damage and fibrosis in human and experimental atrial fibrillation.

Authors:  Zengxiang Dong; Chaolan Lin; Yujiao Liu; Hongbo Jin; Hong Wu; Zhenjun Li; Liping Sun; Lu Zhang; Xi Hu; Yingying Wei; Chengcheng Wang; Wei Han
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

Review 6.  Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.

Authors:  David Bode; Lukas Semmler; Christian U Oeing; Alessio Alogna; Gabriele G Schiattarella; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

7.  Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis.

Authors:  Hai Liu; Guang-Xian Chen; Meng-ya Liang; Han Qin; Jian Rong; Jian-ping Yao; Zhong-kai Wu
Journal:  BMC Cardiovasc Disord       Date:  2014-01-25       Impact factor: 2.298

8.  Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation.

Authors:  Hai Liu; Han Qin; Guang-xian Chen; Meng-ya Liang; Jian Rong; Jian-ping Yao; Zhong-kai Wu
Journal:  J Transl Med       Date:  2014-04-06       Impact factor: 5.531

9.  Histological and Biochemical Comparisons between Right Atrium and Left Atrium in Patients with Mitral Valvular Atrial Fibrillation.

Authors:  Jae Hyung Park; Jihei Sara Lee; Young-Guk Ko; Seung Hyun Lee; Beom Seob Lee; Seok-Min Kang; Byung Cheol Chang; Hui-Nam Pak
Journal:  Korean Circ J       Date:  2014-07-25       Impact factor: 3.243

10.  Differences in atrial fibrillation‑associated proteins between the left and right atrial appendages from patients with rheumatic mitral valve disease: A comparative proteomic analysis.

Authors:  Hai Liu; Guangxian Chen; Hongsheng Zheng; Han Qin; Mengya Liang; Kangni Feng; Zhongkai Wu
Journal:  Mol Med Rep       Date:  2016-09-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.